XML 37 R26.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Share-Based Compensation | 9 Months Ended
--- | ---
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Share-Based Compensation | Share-Based Compensation The following table presents the details of the Company's share-based compensation expense (in millions):
| Three Months Ended |  | Nine Months Ended
| December 31, |  | December 31,
| 2018 |  | 2017 |  | 2018 |  | 2017
Cost of sales (1) | $ | 3.4 |  |  | $ | 3.5 |  |  | $ | 10.9 |  |  | $ | 10.6 |
Research and development | 19.4 |  |  | 10.9 |  |  | 53.2 |  |  | 31.8 |
Selling, general and administrative | 16.6 |  |  | 9.6 |  |  | 46.1 |  |  | 27.6 |
Special (income) charges and other, net | 0.2 |  |  | — |  |  | 17.3 |  |  | — |
Pre-tax effect of share-based compensation | 39.6 |  |  | 24.0 |  |  | 127.5 |  |  | 70.0 |
Income tax benefit (2) | 8.2 |  |  | 6.6 |  |  | 27.3 |  |  | 21.9 |
Net income effect of share-based compensation | $ | 31.4 |  |  | $ | 17.4 |  |  | $ | 100.2 |  |  | $ | 48.1 |
(1) During the three and nine months ended December 31, 2018, $4.7 million and $12.6 million, respectively, of share-based compensation expense was capitalized to inventory and $3.4 million and $10.9 million, respectively, of previously capitalized share-based compensation expense in inventory was sold. During the three and nine months ended December 31, 2017, $3.1 million and $8.9 million, respectively, of share-based compensation expense was capitalized to inventory and $3.5 million and $10.6 million, respectively, of previously capitalized share-based compensation expense in inventory was sold. (2) Amounts exclude excess tax benefits related to share-based compensation of $4.1 million and $13.1 million, respectively, for the three and nine months ended December 31, 2018 and $5.7 million and $19.8 million, respectively, for the three and nine months ended December 31, 2017. Microsemi Acquisition-related Equity Awards In connection with its acquisition of Microsemi, the Company assumed certain restricted stock units (RSUs), stock appreciation rights (SARs), and stock options granted by Microsemi. The assumed awards were measured at the acquisition date based on the estimated fair value, which was a total of $175.4 million. A portion of that fair value, $53.9 million, which represented the pre-acquisition vested service provided by employees to Microsemi, was included in the total consideration transferred as part of the acquisition. As of the acquisition date, the remaining portion of the fair value of those awards was $121.5 million, representing post-acquisition share-based compensation expense that will be recognized as these employees provide service over the remaining vesting periods. During the nine months ended December 31, 2018, the Company recognized $53.5 million of share-based compensation expense in connection with the acquisition of Microsemi, of which $2.6 million was capitalized into inventory and $17.3 million was due to the accelerated vesting of outstanding equity awards upon termination of certain Microsemi employees.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration